AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Novonesis AS

Director's Dealing Aug 17, 2020

3377_rpt_2020-08-17_33ce4d09-fa06-4d52-b3ea-d4cc2496b543.pdf

Director's Dealing

Open in Viewer

Opens in native device viewer

Trading by management and close relations of management

Pursuant to Article 19 of Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (market abuse regulation) and Commission Delegated Regulation (EU) 1052/2016 of 8 March 2016, Novozymes hereby publishes the following transactions under ISIN code DK0060336014, Novozymes B shares (ticker symbol NZYM B). This sale has been conducted pursuant to Novo Holdings A/S' previously announced intention, to maintain its relative holding of approximately 25.5% of the total shares which was the level prior to Novozymes' reduction of shares on March 27, 2020 (company announcement no. 20, 2020).

Today, Novozymes has entered into an agreement to purchase 765,000 B shares (nominal DKK 2.00) of a value of DKK 279,706,950 from Novo Holdings A/S. This transaction is part of Novozymes' 2020 share repurchase programme of up to a total of DKK 1.5 billion to be executed during 2020. The transaction price is DKK 365.63 per share and has been calculated as the volume weighted average market price from August 13 to 17, 2020 in the open window following the announcement of Novozymes' financial results for the first half of 2020.

August 17, 2020 Company announcement No. 51

Contact information [email protected]

Tobias Cornelius Björklund +45 3077 8682 [email protected]

Carl Ahlgren +1 919 702 6144 [email protected]

Ulrik Wu Svare +45 3077 3187 [email protected]

About Novozymes

Novozymes is the world leader in biological solutions. Together with customers, partners and the global community, we improve industrial performance while preserving the planet's resources and helping build better lives. As the world's largest provider of enzyme and microbial technologies, our bioinnovation enables higher agricultural yields, low-temperature washing, energyefficient production, renewable fuel and many other benefits that we rely on today and in the future. We call it Rethink Tomorrow. www.novozymes.com

Novozymes A/S CVR number: 10 00 71 27 LEI: 529900T6WNZXD2R3JW38

Novozymes A/S Krogshoejvej 36 2880 Bagsvaerd Denmark

Phone: +45 4446 0000

Details of the person discharging managerial responsibilities/person closely associated

Name Novo Holdings A/S

Reason for notification
Position/status The CEO of Novo Holdings A/S serves on the Board of Directors of Novozymes A/S, and
thus, Novo Holdings A/S is a related party of Novozymes A/S
Initial notification/ Initial notification
amendment

Details of the issuer

Entity Novozymes A/S
LEI code 529900T6WNZXD2R3JW38

Details of the transaction(s)

Description:
Financial instrument Shares
Identification code ISIN DK0060336014
Nature of the transaction Sale of shares
Place(s) of transaction(s),
price(s) and volume(s) Place(s) Price(s) Volume(s)
Outside a trading venue 365.63 DKK 765,000 shares
Aggregated information Number of shares: 765,000
Average price, DKK: 365.63
Transaction value, DKK: 279,706,950
Date of the transaction 2020-08-17

Talk to a Data Expert

Have a question? We'll get back to you promptly.